4//SEC Filing
TEPPER ROBERT I 4
Accession 0000899243-22-028793
CIK 0001640266other
Filed
Aug 15, 8:00 PM ET
Accepted
Aug 16, 4:22 PM ET
Size
13.4 KB
Accession
0000899243-22-028793
Insider Transaction Report
Form 4
Third Rock Ventures III, L.P.
10% Owner
Transactions
- Sale
Common Stock
2022-08-15$6.04/sh−135,808$820,280→ 5,907,361 total - Sale
Common Stock
2022-08-12$6.12/sh−348,007$2,129,803→ 6,043,169 total
Holdings
- 36,701
Common Stock
Third Rock Ventures GP III, L.P.
10% Owner
Transactions
- Sale
Common Stock
2022-08-15$6.04/sh−135,808$820,280→ 5,907,361 total - Sale
Common Stock
2022-08-12$6.12/sh−348,007$2,129,803→ 6,043,169 total
Holdings
- 36,701
Common Stock
TEPPER ROBERT I
10% Owner
Transactions
- Sale
Common Stock
2022-08-15$6.04/sh−135,808$820,280→ 5,907,361 total - Sale
Common Stock
2022-08-12$6.12/sh−348,007$2,129,803→ 6,043,169 total
Holdings
- 36,701
Common Stock
TRV GP III, LLC
10% Owner
Transactions
- Sale
Common Stock
2022-08-15$6.04/sh−135,808$820,280→ 5,907,361 total - Sale
Common Stock
2022-08-12$6.12/sh−348,007$2,129,803→ 6,043,169 total
Holdings
- 36,701
Common Stock
Footnotes (4)
- [F1]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.376, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (1).
- [F2]These shares are directly held by Third Rock Ventures III, L.P. ("TRV III"). The general partner of TRV III is Third Rock Ventures GP III, L.P. ("TRV GP III"). The general partner of TRV GP III is TRV GP III, LLC ("TRV GP III LLC"). The individual manager of TRV GP III LLC is Dr. Robert Tepper ("Tepper"). Each of TRV GP III, TRV GP III LLC, and Tepper disclaims beneficial ownership of the shares except to the extent of its or his pecuniary interest therein, if any, and this report shall not be deemed an admission that it or he is the beneficial owner of such shares.
- [F3]The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.00 to $6.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3).
- [F4]The shares are directly held by Tepper.
Documents
Issuer
Voyager Therapeutics, Inc.
CIK 0001640266
Entity typeother
Related Parties
1- filerCIK 0001192595
Filing Metadata
- Form type
- 4
- Filed
- Aug 15, 8:00 PM ET
- Accepted
- Aug 16, 4:22 PM ET
- Size
- 13.4 KB